Anticancer agent 269
Anticancer agent 269 (Compound 11c) is an orally active caspase-3 activator that promotes ROS generation by activating caspase-3, induces cancer cell apoptosis (Apoptosis), and exhibits significant anticancer activity. It can be used for research in the field of cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Caspase; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Cancer
Smiles
ClC1=CC=C(C2=NOC(C3=CC=C(C)C4=C3[Se]N=N4)(C)C2)C=C1
Molecular Formula
C17H14ClN3OSe
Molecular Weight
390.73
References & Citations
[1]Enneiymy M, et al. In-Silico Analysis of Benzo-Selenadiazole Hybrids: Reactivity and Anticancer Potential Assessed Through DFT, Molecular Dynamics, Molecular Docking, and ADMET[J]. Polycyclic Aromatic Compounds, 2025: 1-23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
QP13520-10ug 10ug
Recombinant Human SLAMF7 Protein, His, Insect-10ug
Sign In for Pricing
View Details 
031994-AP 200 µL
APOOL, CT (APOOL, CXorf33, FAM121A, Apolipoprotein O-like, Protein FAM121A) (AP) discontinued
Sign In for Pricing
View Details